Le Lézard
Classified in: Health
Subjects: CHI, SVY

National Report: Alabama Ranks 41st in Protecting Kids from Tobacco


WASHINGTON, Dec. 13, 2017 /PRNewswire-USNewswire/ -- Alabama ranks 41st nationwide in funding programs that prevent kids from smoking and help smokers quit, according to a report released today by leading public health organizations. Alabama is spending $1.3 million this year on tobacco prevention and cessation programs, which is just 2.3 percent of the $55.9 million recommended by the Centers for Disease Control and Prevention (CDC).

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

The report challenges states to do more to fight tobacco use ? the nation's leading cause of preventable death ? and make the next generation tobacco-free. In Alabama, 14 percent of high school students smoke, and 2,600 kids become regular smokers each year. Tobacco use claims 8,600 Alabama lives and costs the state $1.9 billion in health care bills annually.

Other key findings in the report include:

The report ? "Broken Promises to Our Children: A State-by-State Look at the 1998 Tobacco Settlement 19 Years Later" ? was released by the Campaign for Tobacco-Free Kids, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, the Robert Wood Johnson Foundation, Americans for Nonsmokers' Rights and Truth Initiative.

The report spotlights the need for stronger tobacco prevention efforts in Alabama. With one of the highest high school (14 percent) and adult (21.5 percent) smoking rates, Alabama does little to protect its residents from the dangers of tobacco.

"By failing to adequately fund tobacco prevention and cessation programs, Alabama is putting kids' health at risk and costing taxpayers more in tobacco-related health care costs," said Matthew L. Myers, President of the Campaign for Tobacco-Free Kids. "We can win the fight against tobacco and make the next generation tobacco-free, but Alabama needs to do its part to help us achieve these goals."

The U.S. has reduced smoking to record lows ? 15.1 percent among adults and 8 percent among high school students. But tobacco use still kills more than 480,000 Americans and costs the nation about $170 billion in health care bills each year.

Today's report also highlights large disparities in who smokes and who suffers from tobacco-related diseases in the United States. Smoking rates are especially high in a swath of 12 states in the Midwest and South, including Alabama, an area called "Tobacco Nation" in a recent Truth Initiative report. Nationwide, smoking rates are highest among people who live below the poverty level and have less education, American Indians/Alaska Natives, LGBT Americans, those who are uninsured or on Medicaid, and those with mental illness. These differences are in large part due to the tobacco industry's targeting of vulnerable populations through advertising, price discounting and other marketing strategies.

By funding tobacco prevention and cessation programs at the CDC's recommended levels, states can reduce tobacco use among all Americans. But most states are falling far short:

The report and state-specific information can be found at tfk.org/statereport.

 

SOURCE Campaign for Tobacco-Free Kids


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: